• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anixa Biosciences, Inc. - Common Stock (NQ:ANIX)

2.780 +0.070 (+2.58%)
Delayed Quote Updated: 4:00 PM EDT, Oct 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 153,996
Open 2.700
Bid (Size) 2.860 (700)
Ask (Size) 2.960 (4,000)
Prev. Close 2.710
Today's Range 2.680 - 2.780
52wk Range 2.320 - 5.457
Shares Outstanding 33,527,858
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Join Anixa Biosciences' Live Investor Webinar: Advancing Innovative CAR-T Therapy for Ovarian Cancer and a First-in-Class Breast Cancer Vaccine
October 13, 2026
Learn how Anixa is advancing two clinical-stage oncology programs through differentiated immunotherapy and vaccine approaches Management to discuss CAR-T clinical progress, completed Phase 1 breast... 
From RedChip Companies, Inc. (Media Suite)
Via ACCESS Newswire
News headline image
Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
September 11, 2026
From RedChip Companies, Inc. (Media Suite)
Via ACCESS Newswire

Performance

52-Week Range 49.1% below 52-week high
2.780
2.3252W Low 5.4652W High
1 Week 1.4% below 1-week high
2.601W Low 2.821W High

Anixa Biosciences, Inc. - Common Stock (ANIX) traded between $2.32 and $5.46 over the past 52 weeks and last traded at $2.78, 49.1% below its 52-week high. Over the past week it ranged between $2.60 and $2.82.

Past 12 Months
N/A
+3.0%
-21.0%
-11.5%
-12.0%
-33.5%
1W  
1M +$0.08
3M -$0.74
6M -$0.36
YTD -$0.38
1Y -$1.40

ANIX was -33.5% over the past year, -11.5% over six months, -12.0% year to date.

12 Months vs Market
ANIX
-33.5%
DIA
+12.5%
SPY
+13.8%
QQQ
+15.2%
IWM
+12.0%

Over the past 12 months ANIX returned -33.5% versus DIA (Dow) +12.5%, SPY (S&P 500) +13.8%, QQQ (Nasdaq 100) +15.2% and IWM (Russell 2000) +12.0%.

Volume & Liquidity 0.54× 3-mo avg
Today 153,996 3-mo avg 285.7K
1W
144.1K
1M
270.6K
3M
285.7K
6M
242.6K
YTD
208.5K
1Y
223.7K

ANIX most recently traded 153,996 shares against a 3-month average daily volume of 285.7K.

More News

Read More
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
July 17, 2026
Via Benzinga
News headline image
Anixia Biosciences and OwlTing Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
May 01, 2026
Via ACCESS Newswire
News headline image
Recap: Anixa Biosciences Q1 Earnings ↗
March 12, 2024
Via Benzinga
News headline image
Replays from RedChip's Biotech Investor Conference Now Available
April 20, 2026
Via ACCESS Newswire
News headline image
RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation
April 10, 2026
Via ACCESS Newswire
BioMedNewsBreaks — Anixa Biosciences, Inc. (NASDAQ: ANIX) CAR-T Co-Inventor To Keynote SCTR 2026 Retreat
February 25, 2026
Via Investor Brand Network
Water Tower Research Publishes Initiation of Coverage Report on Anixa Biosciences, Inc., “Anixa’s T-Cell Innovations Show Breakthrough Potential in Solid Tumors”
January 21, 2026
Via TheNewswire.com
News headline image
3 Under-the-Radar Biotechs Under $5 That Could Soar 200% ↗
September 09, 2025
Via MarketBeat
News headline image
EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent ↗
April 09, 2025
Via Benzinga
Topics Intellectual Property
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
April 08, 2025
Via Benzinga
News headline image
EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines ↗
March 25, 2025
Via Benzinga
News headline image
EXCLUSIVE: Anixa Biosciences Poised To Receive US Patent For Ovarian Cancer Vaccine ↗
March 24, 2025
Via Benzinga
Topics Intellectual Property
News headline image
This ACNB Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday ↗
March 21, 2025
Via Benzinga
News headline image
iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024
December 06, 2024
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
October 30, 2024
Via Benzinga
News headline image
Anixa Biosciences And 3 Other Stocks Under $5 Insiders Are Buying ↗
July 29, 2024
Via Benzinga
News headline image
EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy ↗
July 23, 2024
Via Benzinga
News headline image
EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued, Launches $5M Stock Buyback Program ↗
July 15, 2024
Via Benzinga
News headline image
ANIX Stock Earnings: Anixa Biosciences Beats EPS for Q2 2024 ↗
June 04, 2024
Via InvestorPlace
News headline image
7 Penny Biotech Stocks to Triple Your Investment ↗
May 28, 2024
Via InvestorPlace
Anixa Biosciences, Inc. (NASDAQ: ANIX) Featured in Coverage of the EF Hutton Annual Global Conference
May 16, 2024
Via Investor Brand Network
News headline image
Sidoti Events, LLC's Virtual May Micro-Cap Conference
May 07, 2024
Via ACCESSWIRE
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
March 20, 2024
Via AB Newswire

Frequently Asked Questions

Is Anixa Biosciences, Inc. - Common Stock publicly traded?
Yes, Anixa Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Anixa Biosciences, Inc. - Common Stock trade on?
Anixa Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Anixa Biosciences, Inc. - Common Stock?
The ticker symbol for Anixa Biosciences, Inc. - Common Stock is ANIX on the Nasdaq Stock Market
What is the current price of Anixa Biosciences, Inc. - Common Stock?
The current price of Anixa Biosciences, Inc. - Common Stock is 2.780
When was Anixa Biosciences, Inc. - Common Stock last traded?
The last trade of Anixa Biosciences, Inc. - Common Stock was at 10/22/26 04:00 PM ET
What is the market capitalization of Anixa Biosciences, Inc. - Common Stock?
The market capitalization of Anixa Biosciences, Inc. - Common Stock is 93.21M
How many shares of Anixa Biosciences, Inc. - Common Stock are outstanding?
Anixa Biosciences, Inc. - Common Stock has 93M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap